Hematopoietic stem cell transplantation for severe rheumatoid arthritis (Q35204112)

7 August 2017

1 reference

title

Hematopoietic stem cell transplantation for severe rheumatoid arthritis (English)

1 reference

7 August 2017

0 references

Moore JJ

1

1 reference

7 August 2017

Snowden J

2

1 reference

7 August 2017

Pavletic S

3

1 reference

7 August 2017

Barr W

4

1 reference

7 August 2017

Burt R

5

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Bone Marrow Transplantation

7 August 2017

published in

1 reference

7 August 2017

volume

32 Suppl 1

1 reference

7 August 2017

page(s)

S53-6

1 reference

Haemopoietic stem cell transplantation for autoimmune diseases

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

Bone Marrow Transplantation in Patients with Gold-Induced Marrow Aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

Autologous bone-marrow transplantation for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703944

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703944

1 reference

7 August 2017

1 reference